Lifeboat Foundation

Carnegie Mellon University researchers have pioneered the CMU Array—a new type of microelectrode array for brain computer interface platforms. It holds the potential to transform how doctors are able to treat neurological disorders.

The ultra-high-density microelectrode array (MEA), which is 3D-printed at the nanoscale, is fully customizable. This means that one day, patients suffering from epilepsy or limb function loss due to stroke could have personalized medical treatment optimized for their individual needs.

Continue reading “Researchers pioneer nanoprinting electrodes for customized treatments of neurological disorders” »

Additive manufacturing techniques used to produce metal alloys have gained popularity due to their ability to be fabricated in complex shapes for use in various engineering applications. Yet the majority of studies conducted have centered around developing single-phase materials.

Dr. Kelvin Xie’s team in the Department of Materials Science and Engineering at Texas A&M University employed advanced characterization techniques to reveal the microstructure of the 3D-printed dual-phase multi-principal elements, also known as high entropy alloys (HEAs), that display ultra-strong and ductile properties. This work is a collaboration with Dr. Wen Chen from the University of Massachusetts at Amherst and Dr. Ting Zhu from the Georgia Institute of Technology.

This study was recently published in Nature.

We demonstrate reversible cycle stability for up to 200 000 cycles with 94–96% average Coulombic efficiency for symmetrical δ-MnO2 nanowire capacitors operating across a 1.2 V voltage window in a poly(methyl methacrylate) (PMMA) gel electrolyte. The nanowires investigated here have a Au@δ-MnO2 core@shell architecture in which a central gold nanowire current collector is surrounded by an electrodeposited layer of δ-MnO2 that has a thickness of between 143 and 300 nm. Identical capacitors operating in the absence of PMMA (propylene carbonate (PC), 1.0 M LiClO4) show dramatically reduced cycle stabilities ranging from 2000 to 8,000 cycles. In the liquid PC electrolyte, the δ-MnO2 shell fractures, delaminates, and separates from the gold nanowire current collector. These deleterious processes are not observed in the PMMA electrolyte.

The last decade has brought a lot of attention to the use of microscopic robots (microrobots or nanorobots) for biomedical applications. Now, nanoengineers have developed microrobots that can swim around in the lungs and deliver medication to be used to treat bacterial pneumonia. A new study shows that the microrobots safely eliminated pneumonia-causing bacteria in the lungs of mice and resulted in 100% survival. By contrast, untreated mice all died within three days after infection.

The results are published Nature Materials in the paper, “Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia.”

The microrobots are made using click chemistry to attach antibiotic-loaded neutrophil membrane-coated polymeric nanoparticles to natural microalgae. The hybrid microrobots could be used for the active delivery of antibiotics in the lungs in vivo.

Scientists have been able to direct a swarm of microscopic swimming robots to clear out pneumonia microbes in the lungs of mice, raising hopes that a similar treatment could be developed to treat deadly bacterial pneumonia in humans.

The microbots are made from algae cells and covered with a layer of antibiotic nanoparticles. The algae provide movement through the lungs, which is key to the treatment being targeted and effective.

In experiments, the infections in the mice treated with the algae bots all cleared up, whereas the mice that weren’t treated all died within three days.

There needs to be a radical change to biological wetware in order to handle viruses. What is needed is either nanoparticles or an immunity to all diseases. Crispr is the main path for the biological singularity but it needs to be perfected first as the human body is still a black box due to restrictions. I do believe that mass spectrometry will essentially be key to see the inner world of human biology. Then crispr can make new parts essentially to evolve past our current limits. But either way the biological singularity is needed for survival of human beings for better health.

The coronavirus revealed flaws in the nation’s pandemic plans. The spread of monkeypox shows that the problems remain deeply entrenched.

Foresight Biotech & Health Extension Meeting sponsored by 100 Plus Capital.
Program & apply to join: https://foresight.org/biotech-health-extension-program/

Jennifer Garrison, Buck Institute.
Reframing Health and Aging through the Lens of Reproduct.

Continue reading “Jennifer Garrison, Buck Institute | Reframing Health and Aging through the Lens of Reproduct” »

This year’s Breakthrough Prize in Life Sciences has a strong physical sciences element. The prize was divided between six individuals. Demis Hassabis and John Jumper of the London-based AI company DeepMind were awarded a third of the prize for developing AlphaFold, a machine-learning algorithm that can accurately predict the 3D structure of proteins from just the amino-acid sequence of their polypeptide chain. Emmanuel Mignot of Stanford University School of Medicine and Masashi Yanagisawa of the University of Tsukuba, Japan, were awarded for their work on the sleeping disorder narcolepsy.

The remainder of the prize went to Clifford Brangwynne of Princeton University and Anthony Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics in Germany for discovering that the molecular machinery within a cell—proteins and RNA—organizes by phase separating into liquid droplets. This phase separation process has since been shown to be involved in several basic cellular functions, including gene expression, protein synthesis and storage, and stress responses.

The award for Brangwynne and Hyman shows “the transformative role that the physics of soft matter and the physics of polymers can play in cell biology,” says Rohit Pappu, a biophysicist and bioengineer at Washington University in St. Louis. “[The discovery] could only have happened the way it did: a creative young physicist working with an imaginative cell biologist in an ecosystem where boundaries were always being pushed at the intersection of multiple disciplines.”